Brentuximab vedotin treatment for mycosis fungoides with CD30+ large‐cell transformation in the early stage
In this paper, we bring hope to patients with mycosis fungoides (MF) with CD30+ large‐cell transformation (LCT), which is often a histological marker of poor prognosis and is associated with a mean 5‐year survival of <20%. Although skin biopsy is a painful procedure, it is the only test for early di...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2023-12-01
|
| Serier: | Journal of Cutaneous Immunology and Allergy |
| Online adgang: | https://doi.org/10.1002/cia2.12330 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|